BridgeBio Pharma (2CL.F) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.93
-0.68
-0.43
-0.19

Details

Expected EPS
-0.925011417
Actual EPS
-0.3614325
Surprise EPS
0.56
Surprise Percent
+60.93%

Description

BridgeBio Pharma (2CL.F) has reported earnings of -0.3614325 per share for Q3 2024.

0 Comments

Share your thoughts